Skip to main content
DA / EN

Research Unit of Epilepsy Genetics and Personalized Medicine (Dianalund)

Research areas

At our research unit, we investigate genetic epilepsies with a focus on the relationship between genetic changes, clinical symptoms, and disease course. Our aim is to contribute to improved diagnosis, prognostic assessment, and more targeted treatment – particularly for individuals with rare monogenic epilepsies.

We combine genetic findings with clinical and electroclinical data and collaborate across disciplines to translate new knowledge into clinical practice and contribute to more individualized treatment options.

Uur research aims are:

  • To understand the relationship between genetics and clinical symptoms - We investigate the relationship between specific genetic changes and clinical symptoms and describe the electroclinical characteristics of different genetic epilepsies.
  • To characterize disease course and prognosis - We investigate the natural history of these disorders to improve diagnosis and prognostic assessment.
  • To contribute to more targeted treatment - We investigate the effects of existing treatments as well as the potential of new and alternative treatment strategies, with the aim of contributing to more individualized treatment.
  • To understand the molecular mechanisms underlying genetic epilepsies - In collaboration with basic scientists, we investigate how genetic changes affect biological processes and may lead to epilepsy.
  • To identify new genetic causes of epilepsy - We contribute to the identification of disease-causing genes and genetic variants.

We collaborate with basic scientists, clinicians, the pharmaceutical industry, and patient organizations nationally and internationally. Through these interdisciplinary collaborations, we aim to strengthen our understanding of genetic epilepsies and contribute to the development of more individualized treatment options.

 

Overview of our publications

Last Updated 28.08.2026